Here's How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today
Portfolio Pulse from Benzinga Insights
Over the past 10 years, Regeneron Pharmaceuticals (NASDAQ:REGN) has produced an average annual return of 12.9%, outperforming the market by 1.97%. A $100 investment in REGN a decade ago would now be worth $335.50. The company's current market capitalization stands at $105.76 billion.
April 01, 2024 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown a strong performance over the past decade with an average annual return of 12.9%, turning a $100 investment into $335.50.
The significant growth in investment value over a decade highlights Regeneron Pharmaceuticals' strong performance and its ability to outperform the market. This historical performance, coupled with a substantial market capitalization, suggests a positive outlook for REGN in the short term, potentially attracting more investors.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100